- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06404632
A Group Intervention for Promoting Health-related Habits (LEV-G)
A Group Intervention for Promoting Health-related Habits in Individuals With Disabilities (LEV-G)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Lev is a brief, transdiagnostic, interprofessional intervention targeting health-related habits that is intended for several care settings. The main population intended is individuals with neurodevelopmental disorders or parents or close relations to children with disabilities. This study will therefore be open for participants recruited from several types of healthcare services in Sweden.
Study 1: The feasibility trial investigates the following questions:
Completion: How many participants that started Lev completed the intervention? What were the reasons for not not completing Lev? How many sessions did the participants complete? Lev includes screening (Lev-s), three sessions + one booster session.
Level of acceptability: Was Lev perceived as creditable and satisfactory by healthcare workers and participants? Treatment credibility will be measured before Lev and after the last session for both participants and healthcare workers. Treatment satisfaction will be evaluated after each session and after the intervention is completed. Session evaluations will be done by both participants and healthcare workers.
Do the intervention lead to adverse events? To what extent were individual goals met?
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Joakim Lavesson, Bachelor
- Phone Number: +46 8 123 350 01
- Email: joakim.lavesson@regionstockholm.se
Study Contact Backup
- Name: Douglas Sjöwall, PhD
- Phone Number: +46 (0)739568658
- Email: douglas.sjowall@ki.se
Study Locations
-
-
Stockholm, Sweden
-
Stockholm, Stockholm, Sweden, Sweden, 104 31
- Recruiting
- Region Stockholm
-
Contact:
- Douglas Sjöwall, PhD
- Phone Number: +46 (0)739568658
- Email: douglas.sjowall@ki.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- both adults with and without disabilities recruited from different healthcare contexts.
Exclusion Criteria:
Intellectual disability of the degree where the participant is not able to follow the protocol in Lev.
- Insufficient command of the Swedish language/ unable to understand the content.
- Severe psychiatric comorbidity that makes participation difficult (e.g. severe depression, severe suicidality, severe anxiety, ongoing psychosis, manic episode), other circumstances that could make participation hard (e.g. homelessness).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Lev-g (group intervention)
Lev-g includes three sessions + a booster session using psychoeducation, motivational interviewing, and applied behavioral analyses.
Lev-g is done in groups to enable support and tips from others.
There is no control condition.
Only one arm to test feasibility.
|
Lev-g includes three sessions + a booster session using psychoeducation, motivational interviewing, and applied behavioral analyses.
Lev-g is done in groups to enable support and tips from others.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Completion rate participants
Time Frame: within 3-4 months
|
How many of the participants that started using Lev (i.e., completing screening with Lev-s) completed Lev (i.e., completing, 3 out of 4 session)
|
within 3-4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment satisfaction participants (individual sessions)
Time Frame: After completing the first session in Lev. An average of 1-2 weeks from baseline
|
Treatment satisfaction will be evaluated after session 1 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. After the meeting today, my knowledge of how I can change my lifestyle have increased. I will benefit from what we talked about during the meeting today The content of the meeting felt relevant based on my own experiences I understood the advice and strategies I was given that will help my change mine lifestyle habits I feel confident in how to use the advice and strategies I will use the advice and strategies I was listened to, the therapist understood my situation I was involved and helped to come up with suggestions for how I can reach my goals Is there something else you would like to add? |
After completing the first session in Lev. An average of 1-2 weeks from baseline
|
|
Treatment satisfaction participants (individual sessions)
Time Frame: After completing the second session in Lev. An average of 2-3 weeks from baseline
|
Treatment satisfaction will be evaluated after session 2 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. After the meeting today, my knowledge of how I can change my lifestyle have increased. I will benefit from what we talked about during the meeting today The content of the meeting felt relevant based on my own experiences I understood the advice and strategies I was given that will help my change mine lifestyle habits I feel confident in how to use the advice and strategies I will use the advice and strategies I was listened to, the therapist understood my situation I was involved and helped to come up with suggestions for how I can reach my goals Is there something else you would like to add? |
After completing the second session in Lev. An average of 2-3 weeks from baseline
|
|
Treatment satisfaction participants (individual sessions)
Time Frame: After completing the third session in Lev. An average of 3-4 weeks from baseline
|
Treatment satisfaction will be evaluated after session 3 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. After the meeting today, my knowledge of how I can change my lifestyle have increased. I will benefit from what we talked about during the meeting today The content of the meeting felt relevant based on my own experiences I understood the advice and strategies I was given that will help my change mine lifestyle habits I feel confident in how to use the advice and strategies I will use the advice and strategies I was listened to, the therapist understood my situation I was involved and helped to come up with suggestions for how I can reach my goals Is there something else you would like to add? |
After completing the third session in Lev. An average of 3-4 weeks from baseline
|
|
Treatment satisfaction participants (individual sessions)
Time Frame: After completing the booster session in Lev. An average of 3-4 month from baseline
|
Treatment satisfaction will be evaluated after booster session using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. After the meeting today, my knowledge of how I can change my lifestyle have increased. I will benefit from what we talked about during the meeting today The content of the meeting felt relevant based on my own experiences I understood the advice and strategies I was given that will help my change mine lifestyle habits I feel confident in how to use the advice and strategies I will use the advice and strategies I was listened to, the therapist understood my situation I was involved and helped to come up with suggestions for how I can reach my goals Is there something else you would like to add? |
After completing the booster session in Lev. An average of 3-4 month from baseline
|
|
Treatment satisfaction participants (the three sessions)
Time Frame: Directly after completing the last treatment module in LEV (approximately at 3-4 weeks from baseline)]
|
Treatment satisfaction will be evaluated after competing the three sessions using Patient Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. As a whole, the Lev has been clearly focused on how I can live healthier My knowledge of how I can have healthier habits has increased I can better deal with problems connected to my health-related habits I have had the opportunity to contribute opinions during the Lev I would consider participating in a similar interventions in the future The participants also rated the course as a whole following the school grading system ''Failed,'' ''Passed,'' ''Passed with distinction,'' and ''Passed with special |
Directly after completing the last treatment module in LEV (approximately at 3-4 weeks from baseline)]
|
|
Treatment satisfaction participants (the whole intervention including the booster session)
Time Frame: Directly after completing the last treatment module in LEV (approximately at 3-4 month from baseline)]
|
Treatment satisfaction will be evaluated after competing the whole intervention using Patient Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. As a whole, the Lev has been clearly focused on how I can live healthier My knowledge of how I can have healthier habits has increased I can better deal with problems connected to my health-related habits I have had the opportunity to contribute opinions during the Lev I would consider participating in a similar interventions in the future The participants also rated the course as a whole following the school grading system ''Failed,'' ''Passed,'' ''Passed with distinction,'' and ''Passed with special |
Directly after completing the last treatment module in LEV (approximately at 3-4 month from baseline)]
|
|
Open answer questions regarding Treatment satisfaction measured by The Evaluation Questionnaire for participants
Time Frame: Directly after completing the third session in LEV (approximately at 3-4 weeks from baseline)]
|
The treatment satisfaction questionnaire also included open questions that will be analyses using a qualitative thematic approach including the following questions: I feel that participating in Lev helped me in these ways How could the Lev have been better? What could I have done differently myself? Is there anything else you would like to add? A qualitative, thematic analysis will be performed to identify more general themes. There is not a template or scale to extract the themes. One rater suggest categories based on the similarity of answers. Another rater organizes the answers in the suggested themes. To be considered a theme, there must be over 85% similarity between raters. I would consider participating in a similar interventions in the future The participants also rated the course as a whole following the school grading system ''Failed,'' ''Passed,'' ''Passed with distinction,'' and ''Passed with special |
Directly after completing the third session in LEV (approximately at 3-4 weeks from baseline)]
|
|
Open answer questions regarding Treatment satisfaction measured by The Evaluation Questionnaire for participants
Time Frame: Directly after completing the booster session in LEV (approximately at 3-4 month from baseline)]
|
The treatment satisfaction questionnaire also included open questions that will be analyses using a qualitative thematic approach including the following questions: I feel that participating in Lev helped me in these ways How could the Lev have been better? What could I have done differently myself? Is there anything else you would like to add? A qualitative, thematic analysis will be performed to identify more general themes. There is not a template or scale to extract the themes. One rater suggest categories based on the similarity of answers. Another rater organizes the answers in the suggested themes. To be considered a theme, there must be over 85% similarity between raters. I would consider participating in a similar interventions in the future. The participants also rated the course as a whole following the school grading system ''Failed,'' ''Passed,'' ''Passed with distinction,'' and ''Passed with special |
Directly after completing the booster session in LEV (approximately at 3-4 month from baseline)]
|
|
Treatment satisfaction healthcare workers (individual sessions)
Time Frame: After completing the first session in Lev. An average of 1-2 weeks from baseline
|
Treatment satisfaction will be evaluated after session 1 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. The content of this session feels relevant The degree of difficulty in conveying the content of the session is at a reasonable level for me as a therapist Is there something else you would like to add? |
After completing the first session in Lev. An average of 1-2 weeks from baseline
|
|
Treatment satisfaction healthcare workers (individual sessions)
Time Frame: After completing the first session in Lev. An average of 2-3 weeks from baseline
|
Treatment satisfaction will be evaluated after session 2 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. The content of this session feels relevant The degree of difficulty in conveying the content of the session is at a reasonable level for me as a therapist Is there something else you would like to add? |
After completing the first session in Lev. An average of 2-3 weeks from baseline
|
|
Treatment satisfaction healthcare workers (individual sessions)
Time Frame: After completing the first session in Lev. An average of 3-4 weeks from baseline
|
Treatment satisfaction will be evaluated after session 3 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. The content of this session feels relevant The degree of difficulty in conveying the content of the session is at a reasonable level for me as a therapist Is there something else you would like to add? |
After completing the first session in Lev. An average of 3-4 weeks from baseline
|
|
Treatment satisfaction healthcare workers (individual sessions)
Time Frame: After completing the first session in Lev. An average of 3-4 months from baseline
|
Treatment satisfaction will be evaluated after the booster session using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. The content of this session feels relevant The degree of difficulty in conveying the content of the session is at a reasonable level for me as a therapist Is there something else you would like to add? |
After completing the first session in Lev. An average of 3-4 months from baseline
|
|
Well-being before and after the intervention measures by The Evaluation Questionnaire
Time Frame: Directly after completing the third treatment module in LEV (approximately at 3-4 weeks)
|
("How would you rate your well-being prior to the intervention?",
"How would you rate your current well-being") at T1 and T2 on a scale 1-10 (1= very poor, 10= very good)
|
Directly after completing the third treatment module in LEV (approximately at 3-4 weeks)
|
|
Well-being before and after the intervention measures by The Evaluation Questionnaire
Time Frame: Directly after completing the booster session module in LEV (approximately at 3-4 months)
|
("How would you rate your well-being prior to the intervention?",
"How would you rate your current well-being") at T1 and T2 on a scale 1-10 (1= very poor, 10= very good)
|
Directly after completing the booster session module in LEV (approximately at 3-4 months)
|
|
Adverse events after the intervention
Time Frame: During the intervention up to week approximately 3-4 months
|
Adverse events will be defined as spontaneous oral complaints or instances when patients stated that they experienced negative or unwanted effects during the intervention period. Serious adverse events will be defined as events that involved hospital care/hospitalization, etc. due to the intervention. |
During the intervention up to week approximately 3-4 months
|
|
To what extent were individual goals met?
Time Frame: Directly after completing the third treatment module in LEV (approximately at 3-4 weeks)
|
The healthcare worker assesses to what extent the goals have been met using the goal attainment scale.
5 point scale where high vales indicate that goals have been reached to a higher extent.
|
Directly after completing the third treatment module in LEV (approximately at 3-4 weeks)
|
|
To what extent were individual goals met?
Time Frame: Directly after completing the booster session module in LEV (approximately at 3-4 months)
|
The healthcare worker assesses to what extent the goals have been met using the goal attainment scale.
5 point scale where high vales indicate that goals have been reached to a higher extent.
|
Directly after completing the booster session module in LEV (approximately at 3-4 months)
|
|
Self-efficacy for promoting health behaviors for their children
Time Frame: Directly after completing the third session in LEV (approximately at 3-4 weeks)
|
Participants are asked to assess self-efficacy for promoting health behaviors using the "Parental self-efficacy for healthy dietary and physical activity behaviors in preschool children (PDAP) including 24 items on a 0-10 point scale where high values indicate higher self-efficacy
|
Directly after completing the third session in LEV (approximately at 3-4 weeks)
|
|
Self-efficacy for promoting health behaviors for their children
Time Frame: Directly after completing the booster session in LEV (approximately at 3-4 month)
|
Participants are asked to assess self-efficacy for promoting health behaviors using the "Parental self-efficacy for healthy dietary and physical activity behaviors in preschool children (PDAP) including 24 items on a 0-10 point scale where high values indicate higher self-efficacy
|
Directly after completing the booster session in LEV (approximately at 3-4 month)
|
|
Do Lev lead to healthier habits?
Time Frame: Before and after taking part in Lev (after is after the third, 3-4 weeks, as wells as after the booster session, 3-4 month)
|
The Lev-s will be used to measure diet and physical activity before and after taking part in Lev.
The scale includes 4 levels where higher levels indicate healthier habits.
|
Before and after taking part in Lev (after is after the third, 3-4 weeks, as wells as after the booster session, 3-4 month)
|
|
Level of treatment credibility participants
Time Frame: Before and after taking part in Lev (after refers to completing the three sessions i.e, not including the booster session after three months). I.e within 6 weeks
|
Was Lev perceived as creditable by participants using Treatment and Credibility Scale.
Four items for credibility and one for expectation on a 10 point Likert scale where higher values indicate higher credibility.
|
Before and after taking part in Lev (after refers to completing the three sessions i.e, not including the booster session after three months). I.e within 6 weeks
|
|
Level of treatment credibility healthcare workers
Time Frame: Before and after taking part in Lev (after refers to completing the three sessions i.e, not including the booster session after three months)I.e within 6 weeks
|
Was Lev perceived as creditable by healthcare workers using Treatment and Credibility Scale .
Four items for credibility and one for expectation on a 10 point Likert scale where higher values indicate higher credibility.
|
Before and after taking part in Lev (after refers to completing the three sessions i.e, not including the booster session after three months)I.e within 6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Douglas Sjöwall, PhD, Region Stockholm
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- The LEV Project (group)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health-Related Behavior
-
Istinye UniversityRecruitingHealth-Related BehaviorTurkey (Türkiye)
-
University of Texas Rio Grande ValleyHealth and Human Services Commission (HHSC); Pharr-San Juan-Alamo Independent... and other collaboratorsCompletedHealth-Related BehaviorUnited States
-
University of PrimorskaUniversity of Ljubljana, Faculty of Social Sciences; Ministry of Defence, SloveniaActive, not recruitingHealth-Related BehaviorSlovenia
-
Holbaek SygehusCompletedHealth Behavior | Health Knowledge, Attitudes, Practice | Health-Related Behavior | Health LiteracyDenmark
-
Boston Children's HospitalAllan & Gill Gray FoundationCompletedSleep | Health-Related BehaviorUnited States
-
Boston Children's HospitalRecruitingSleep | Health-Related BehaviorUnited States
-
The University of Texas at DallasRecruitingHealth-Related Behavior | Healthy LifestyleUnited States
-
Research on Healthcare Performance Lab U1290RecruitingStress | Health Behavior | Health-Related BehaviorFrance
-
Imperial College LondonRecruitingHealth Attitude | Disease | Cancer | Health Behavior | Health Knowledge, Attitudes, Practice | Health-Related BehaviorUnited Kingdom
-
Universiti Teknologi MaraUniversiti Putra Malaysia; Ministry of Health, Malaysia; Institute for Health... and other collaboratorsRecruitingHealth Attitude | Health Behavior | Knowledge, Attitudes, Practice | Health Knowledge, Attitudes, Practice | Health-Related Behavior | Behavior, Health | Attitude to Health | Preparedness | OutbreaksMalaysia
Clinical Trials on Lev-g
-
Washington University School of MedicineCompletedSubarachnoid HemorrhageUnited States
-
Region StockholmKarolinska InstitutetCompletedQuality of Life | Feasibility | Health-Related Behavior | Disability Physical | Life Style | Mental Health Wellness | Intervention | Disabilities PhysicalSweden
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Region ZealandNot yet recruitingDiabetes Mellitus, Type 2 | Randomized Controlled TrialDenmark
-
Programme National de Lutte contre l'Onchocercose...CompletedOnchocerciasis, Ocular | LoiasisCongo
-
GlaxoSmithKlineCompletedRhinitis, Allergic, Perennial and SeasonalAustralia
-
UCB Japan Co. Ltd.CompletedEpilepsy | Partial Onset SeizuresJapan
-
Vanderbilt University Medical CenterCompletedSchizophrenia; PsychosisUnited States
-
UCB Japan Co. Ltd.Completed
-
UCB PharmaCompletedEpilepsy, PartialUnited States, France, United Kingdom, Germany, Belgium, Mexico, Poland, India, Romania, South Africa, Canada, Brazil, Russian Federation, Czech Republic, Hungary, Italy
-
Sunnybrook Health Sciences CentreUniversity Health Network, Toronto; Weston Brain InstituteRecruitingHippocampal Hyperactivation | Prodromal Alzheimer DiseaseCanada